Literature DB >> 19345223

A culture amplified multi-parametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses.

C Mee Ling Munier1, John J Zaunders, Susanna Ip, David A Cooper, Anthony D Kelleher.   

Abstract

Ex-vivo T-cell responses to vaccines and some viral antigens are not always detectable by conventional functional T-cell assays such as lympho-proliferation assays, IFN-gamma ELIspot and intracellular cytokine staining (ICC). In this study we describe the development, optimisation and utilisation of a culture amplified multiparametric intracellular cytokine assay (CAMP-ICC) to detect antigen specific T-cells that may be present at low frequencies and small primed responses typical of those induced by DNA vaccines in humans. CFSE labelled PBMCs are cultured for 10 days with antigens of interest. Low concentrations of exogenous proliferative and anti-apoptotic cytokines are added to assist in amplification of the antigen specific, but not background responses. On day 10 the cultured cells are re-challenged with or without antigen as for the standard ICC and then stained with fluorescent monoclonal antibodies of interest. Various conditions, including concentration, day of administration and length of incubation were tested employing the cytokines, IL-2, IL-7, IL-15 and IL-21 alone or in combination. CMV lysate, CEF peptides and measles viral lysate were used in the optimisation of the CAMP-ICC. We found that addition of 0.5 ng/ml of IL-15 in combination with 0.1 ng/ml of IL-21 at day 5 of culture enhanced proliferation of antigen specific responses whilst maintaining low background. The CAMP-ICC provides much more information than conventional functional T-cell assays allowing simultaneous determination of proliferative capacity and cytokine production by both CD4 and CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345223     DOI: 10.1016/j.jim.2009.03.013

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV).

Authors:  Daniel D Murray; John Zaunders; Samuel T Milliken; C Mee Ling Munier; Carole Ford; C Orla Morrissey; Malini Visweswaran; Sharon Avery; Joseph Sasadeusz; John Kwan; Shrinivas Desai; Matthew Law; Kersten K Koelsch; Sharon R Lewin; John Moore; Anthony D Kelleher; Mark N Polizzotto
Journal:  Clin Infect Dis       Date:  2021-04-08       Impact factor: 9.079

2.  Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.

Authors:  Shuhei Karakawa; Satoshi Okada; Miyuki Tsumura; Yoko Mizoguchi; Norioki Ohno; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Tomoki Kawai; Ryuta Nishikomori; Takemasa Sakaguchi; Yoshihiro Takihara; Masao Kobayashi
Journal:  J Clin Immunol       Date:  2011-07-01       Impact factor: 8.317

3.  Proliferation assay amplification by IL-2 in model primary and recall antigen systems.

Authors:  Amy S M Kennell; Keith G Gould; Myer R Salaman
Journal:  BMC Res Notes       Date:  2014-09-20

4.  Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.

Authors:  Anja Ten Brinke; Natalia Marek-Trzonkowska; Maria J Mansilla; Annelies W Turksma; Karolina Piekarska; Dorota Iwaszkiewicz-Grześ; Laura Passerini; Grazia Locafaro; Joan Puñet-Ortiz; S Marieke van Ham; Maria P Hernandez-Fuentes; Eva M Martínez-Cáceres; Silvia Gregori
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

5.  Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.

Authors:  John Zaunders; Wayne B Dyer; Melissa Churchill; C Mee Ling Munier; Philip H Cunningham; Kazuo Suzuki; Kristin McBride; Will Hey-Nguyen; Kersten Koelsch; Bin Wang; Bonnie Hiener; Sarah Palmer; Paul R Gorry; Michelle Bailey; Yin Xu; Mark Danta; Nabila Seddiki; David A Cooper; Nitin K Saksena; John S Sullivan; Sean Riminton; Jenny Learmont; Anthony D Kelleher
Journal:  J Virus Erad       Date:  2019-04-01

6.  Enhancing the Detection of Brucella-Specific CD4+ T Cell Responses in Cattle via in vitro Antigenic Expansion and Restimulation.

Authors:  Paola M Boggiatto; Robert G Schaut; Steven C Olsen
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.